Expression changes of neurofilament subunits in the central nervous system of hens treated with tri-ortho-cresyl phosphate (TOCP)

Toxicology

Volumn 223, Issue 1-2, 2006, Pages 127-135

  Zhao, Xiu lan ^a   Zhang, Tian liang ^b   Zhang, Cui li ^a   Han, Xiao ying ^c   Yu, Su fang ^a   Li, Shan xia ^d   Cui, Ning ^e   Xie, Ke qin ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Institute for Prevention and Treatment of Endemic Disease   (China)

^c SHANDONG NORMAL UNIVERSITY   (China)

^d Institute for Health Inspection and Supervision   (China)

^e SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Neurofilament subunits; Organophosphorus ester induced delayed neuropathy (OPIDN); Reverse transcription polymerase chain reaction (RT PCR); Tri ortho cresyl phosphate (TOCP); Western blotting

Indexed keywords

NEUROFILAMENT PROTEIN; TRI ORTHO CRESYL PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; HEN; IMMUNOBLOTTING; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SPINAL CORD;

ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CHICKENS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; NEUROFILAMENT PROTEINS; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TRITOLYL PHOSPHATES;

EID: 33646556459     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.03.008     Document Type: Article

References (43)

1. Abou-Donia M.B. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 87 (1993) 383-393
2. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health 58 8 (2003) 484-497
3. Abou-Donia M.B., and Graham D.G. Delayed neurotoxicity of O-ethyl-O-4-nitrophenyl phenylphosphonothioate: toxic effects of single oral dose on the nervous system of hens. Toxicol. Appl. Pharmacol. 48 (1979) 57-66
4. Abou-Donia M.B., and Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and Type II. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 405-440
5. Carlson K., and Ehrich M. Organophosphorus compound-induced modification of SH-SY5Y human neuroblastoma mitochondrial transmembrane potential. Toxicol. Appl. Pharmacol. 160 1 (1999) 33-42
6. Carlson K., Jortner B.S., and Ehrich M. Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma cells. Toxicol. Appl. Pharmacol. 168 (2000) 102-113
7. Ehrich M., and Gross W.B. Modification of TOTP toxicity in chickens by stress. Toxicol. Appl. Pharmacol. 70 (1983) 245-254
8. Ehrich M., and Gross W.B. Effect of supplemental corticosterone and social stress on organophosphorus-induced delayed neuropathy in chickens. Toxicol. Lett. 31 (1986) 9-13
9. Elder G.A., Friedrich Jr. V.L., Margita A., and Lazzarini R.A. Age related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit. J. Cell. Biol. 146 (1999) 181-192
10. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222 (1999) 236-245
11. Giasson B.I., Gromlish J.A., Athlan E.S., and Mushynski W.E. Activation of cyclic AMP-dependent protein kinase in okadaic acid-treated neurons potentiates neurofilament fragmentation and stimulates phosphorylation of Ser2 in the low-molecular-mass neurofilament subunit. J. Neurochem. 66 3 (1996) 1207-1213
12. Goldstein M.E., Sternberger N.H., and Sternberge L.A. Phosphorylation protects neurofilaments against proteolysis. J. Neuroimmunol. 14 (1987) 149-160
13. Gupta R.C., Milatovic D., and Dettbarn W.D. Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. Neuro. Toxicol. 22 (2001) 271-282
14. Hoffman P.N., Cleveland D.W., Griffin J.W., Landes P.W., Cowan N.J., and Price D.L. Neurofilament gene expression: a major determinant of axonal caliber. Proc. Natl. Acad. Sci. U.S.A. 84 10 (1987) 3472-3476
15. Jensen K.F., Lapadula D.M., and Anderson J.K. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 33 3 (1992) 455-460
16. Johnson M.K. Organophosphorus and other inhibitors of brain "neurotoxic esterase" and the development of delayed neurotoxicity in hens. Biochem. J. 120 (1970) 523-531
17. Jortner B.S., Hancock S.K., Hinckley J., Flory L., Tobias L., Williams L., and Ehrich M. Neuropathological studies of rats following multiple exposure to tri-ortho-tolyl phosphate, chlorpyrifos and stress. Toxicol. Pathol. 33 3 (2005) 378-385
18. Jortner B.S., Perkins S.K., and Ehrich M. Immunohistochemical study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology 20 6 (1999) 971-975
19. Julien J.P., and Mushynski W.E. Neuroflaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 61 (1998) 1-23
20. Lapadula E.S., Lapadula D.M., and Abou-Donia M.B. Biochemical changes in sciatic nerve of hens treated with tri-o-cresyl phosphate: increased phosphorylation of cytoskeletal proteins. Neurochem. Int. 20 2 (1992) 247-255
21. Lariviere R.C., and Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 1 (2004) 131-148
22. Lee M.K., and Cleveland D.W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19 (1996) 187-217
23. Levy E., Liem R.K., D'Eustachio P., and Cowan N.J. Structure and evolutionary origin of the gene encoding mouse NF-M, the middle-molecular-mass neurofilament protein. Eur. J. Biochem. 66 1 (1987) 71-77
24. Lewis S.A., and Cowan N.J. Genetics, evolution, and expression of the 68,000-mol-wt neurofilament protein: isolation of a cloned cDNA probe. J. Cell. Biol. 100 3 (1985) 843-850
25. Liu Q., Xie F., Siedlak S.L., Nunomura A., Honda K., Moreira P.I., Zhua X., Smith M.A., and Perry G. Neurofilament proteins in neurodegenerative diseases. Cell. Mol. Life Sci. 61 24 (2004) 3057-3075
26. LoPachin R.M., He D., Reid M.L., and Opanashuk L.A. 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions. Toxicol. Appl. Pharmacol. 198 (2004) 61-73
27. Massicotte C., Jortner B.S., and Ehrich M. Morphological effects of neuropathy-inducing organophosphorus compounds in primary dorsal root ganglia cell cultures. Neurotoxicology 24 6 (2003) 787-796
28. Mohr E., and Richter D. Axonal mRNAs: functional significance in vertebrates and invertebrates. J. Neurocytol. 29 11-12 (2000) 783-791
29. Moskowitz P.F., and Oblinger M.M. Transcriptional and post-transcriptional mechanisms regulating neurofilament and tubulin gene expression during normal development of the rat brain. Mol. Brain Res. 30 (1995) 211-222
30. Myers M.W., Lazzarini R.A., Lee V.M., Schlaepfer W.W., and Nelson D.L. The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J. 6 6 (1987) 1617-1626
31. Nixon R.A., Paskevich P.A., Sihag R.K., and Thayer C.Y. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J. Cell. Biol. 126 4 (1994) 1031-1046
32. Nixon R.A., and Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14 (1991) 501-506
33. Pant H.C. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem. J. 256 (1988) 665-668
34. Perrone Capano C., Pernas-Alonso R., and di Porzio U. Neurofilament homeostasis and motoneurone degeneration. Bioessays 23 1 (2001) 24-33
35. Roder H.M., Hoffman F.J., and Schroder W. Phosphatase resistance of ERK2 brain kinase PK40erk2. J. Neurochem. 64 5 (1995) 2203-2212
36. Tsujimoto Y. Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell. Death Differ. 4 (1997) 429-434
37. US Environmental Protection Agency, 1998. Health Effect Test Guidelines OPPTS870.6100 Acute and 28-Day Delayed Neurotoxicity of Organophosphorus Substances. EPA 712-C-98-237.
38. Veeranna, Shetty K.T., Link W.T., Jaffe H., Wang J., and Pant H.C. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64 6 (1995) 2681-2690
39. Wagner O.I., Ascano J., Tokito M., Leterrier J.F., Janmey P.A., and Holzbaur E.L. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol. Biol. Cell 15 11 (2004) 5092-5100
40. Wang Y.P., Song J.F., Rao Z.R., and Mou D.L. Spinal cord neuronal apoptosis induced by triorthocresyl phosphate poisoning in hens. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 22 1 (2004) 19-21
41. Watson D.F., Fittro K.P., Hoffman P.N., and Griffin J.W. Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication. Brain Res. 539 1 (1991) 103-109
42. Xie K., Gupta R.P., and Abou-Donia M.B. Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethylsulfonyl fluoride. Neurochem. Res. 26 (2001) 235-243
43. Zhao X.L., Zhu Z.P., Zhang T.L., Zhang C.L., Yu L.H., and Xie K.Q. Tri-ortho-cresyl phosphate (TOCP) decreases the levels of cytoskeletal proteins in hen sciatic nerve. Toxicol. Lett. 152 2 (2004) 139-147